aluates Reports

$ 0.0

Automative

Global Chronic Idiopathic Constipation Treatment Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-30D5575

Global Chronic Idiopathic Constipation Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Chronic Idiopathic Constipation Treatment Market Research Report 2025

Code: QYRE-Auto-30D5575

Report

June 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Allergan plc

Bausch Health

Sanofi

Takeda Pharmaceutical Company

Sebela Pharmaceuticals

Ironwood Pharmaceuticals Inc

Albireo Pharma Inc

Sucampo Pharmaceuticals, Inc. (Mallinckrodt)

Janssen Pharmaceuticals, Inc. (Johnson and Johnson)

Chronic Idiopathic Constipation Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chronic Idiopathic Constipation Treatment Market

The global market for Chronic Idiopathic Constipation Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Chronic idiopathic constipation is a highly prevalent functional bowel disorder that affects millions of individuals worldwide. Some of the major factors that contribute to the burgeoning number of patients suffering from chronic idiopathic constipation include sedentary lifestyle, increasing usage of anti-inflammatory agents, and drastic decline in the intake of dietary fibers. Over the past few years, considerable efforts have been made to improve the management of chronic idiopathic constipation.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Chronic Idiopathic Constipation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Idiopathic Constipation Treatment.

The Chronic Idiopathic Constipation Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Idiopathic Constipation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Idiopathic Constipation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Idiopathic Constipation Treatment Market Report

Report Metric	Details
Report Name	Chronic Idiopathic Constipation Treatment Market
CAGR	5%
Segment by Type	Blood Tests Sigmoidoscopy Colonoscopy Balloon Expulsion Test Anorectal Manometry Colonic Transit Study Defecography Others
Segment by Application	Hospitals Gastroenterology clinics Diagnostic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer AG, Allergan, Bausch Health, Sanofi, Takeda Pharmaceutical Company, SEBELA PHARMACEUTICALS, Ironwood Pharmaceuticals, Inc., Albireo Pharma, Inc., Sucampo Pharmaceuticals, Inc. (Mallinckrodt), Janssen Pharmaceuticals, Inc. (Johnson and Johnson)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Idiopathic Constipation Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Idiopathic Constipation Treatment Market report?

Ans: The main players in the Chronic Idiopathic Constipation Treatment Market are Bayer AG, Allergan, Bausch Health, Sanofi, Takeda Pharmaceutical Company, SEBELA PHARMACEUTICALS, Ironwood Pharmaceuticals, Inc., Albireo Pharma, Inc., Sucampo Pharmaceuticals, Inc. (Mallinckrodt), Janssen Pharmaceuticals, Inc. (Johnson and Johnson)

What are the Application segmentation covered in the Chronic Idiopathic Constipation Treatment Market report?

Ans: The Applications covered in the Chronic Idiopathic Constipation Treatment Market report are Hospitals, Gastroenterology clinics, Diagnostic Centers, Others

What are the Type segmentation covered in the Chronic Idiopathic Constipation Treatment Market report?

Ans: The Types covered in the Chronic Idiopathic Constipation Treatment Market report are Blood Tests, Sigmoidoscopy, Colonoscopy, Balloon Expulsion Test, Anorectal Manometry, Colonic Transit Study, Defecography, Others

Recommended Reports

Bowel Disorders Treatment

Chronic Disease Drugs

Digestive System Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Blood Tests

1.2.3 Sigmoidoscopy

1.2.4 Colonoscopy

1.2.5 Balloon Expulsion Test

1.2.6 Anorectal Manometry

1.2.7 Colonic Transit Study

1.2.8 Defecography

1.2.9 Others

1.3 Market by Application

1.3.1 Global Chronic Idiopathic Constipation Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Gastroenterology clinics

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Idiopathic Constipation Treatment Market Perspective (2020-2031)

2.2 Global Chronic Idiopathic Constipation Treatment Growth Trends by Region

2.2.1 Global Chronic Idiopathic Constipation Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chronic Idiopathic Constipation Treatment Historic Market Size by Region (2020-2025)

2.2.3 Chronic Idiopathic Constipation Treatment Forecasted Market Size by Region (2026-2031)

2.3 Chronic Idiopathic Constipation Treatment Market Dynamics

2.3.1 Chronic Idiopathic Constipation Treatment Industry Trends

2.3.2 Chronic Idiopathic Constipation Treatment Market Drivers

2.3.3 Chronic Idiopathic Constipation Treatment Market Challenges

2.3.4 Chronic Idiopathic Constipation Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue

3.1.1 Global Top Chronic Idiopathic Constipation Treatment Players by Revenue (2020-2025)

3.1.2 Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Chronic Idiopathic Constipation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chronic Idiopathic Constipation Treatment Revenue

3.4 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio

3.4.1 Global Chronic Idiopathic Constipation Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation Treatment Revenue in 2024

3.5 Global Key Players of Chronic Idiopathic Constipation Treatment Head office and Area Served

3.6 Global Key Players of Chronic Idiopathic Constipation Treatment, Product and Application

3.7 Global Key Players of Chronic Idiopathic Constipation Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Idiopathic Constipation Treatment Breakdown Data by Type

4.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Type (2020-2025)

4.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2026-2031)

5 Chronic Idiopathic Constipation Treatment Breakdown Data by Application

5.1 Global Chronic Idiopathic Constipation Treatment Historic Market Size by Application (2020-2025)

5.2 Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chronic Idiopathic Constipation Treatment Market Size (2020-2031)

6.2 North America Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)

6.4 North America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Idiopathic Constipation Treatment Market Size (2020-2031)

7.2 Europe Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)

7.4 Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size (2020-2031)

8.2 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Idiopathic Constipation Treatment Market Size (2020-2031)

9.2 Latin America Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)

9.4 Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size (2020-2031)

10.2 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer AG

11.1.1 Bayer AG Company Details

11.1.2 Bayer AG Business Overview

11.1.3 Bayer AG Chronic Idiopathic Constipation Treatment Introduction

11.1.4 Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.1.5 Bayer AG Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Chronic Idiopathic Constipation Treatment Introduction

11.2.4 Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.2.5 Allergan Recent Development

11.3 Bausch Health

11.3.1 Bausch Health Company Details

11.3.2 Bausch Health Business Overview

11.3.3 Bausch Health Chronic Idiopathic Constipation Treatment Introduction

11.3.4 Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.3.5 Bausch Health Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Chronic Idiopathic Constipation Treatment Introduction

11.4.4 Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.4.5 Sanofi Recent Development

11.5 Takeda Pharmaceutical Company

11.5.1 Takeda Pharmaceutical Company Company Details

11.5.2 Takeda Pharmaceutical Company Business Overview

11.5.3 Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Introduction

11.5.4 Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.5.5 Takeda Pharmaceutical Company Recent Development

11.6 SEBELA PHARMACEUTICALS

11.6.1 SEBELA PHARMACEUTICALS Company Details

11.6.2 SEBELA PHARMACEUTICALS Business Overview

11.6.3 SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Introduction

11.6.4 SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.6.5 SEBELA PHARMACEUTICALS Recent Development

11.7 Ironwood Pharmaceuticals, Inc.

11.7.1 Ironwood Pharmaceuticals, Inc. Company Details

11.7.2 Ironwood Pharmaceuticals, Inc. Business Overview

11.7.3 Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Introduction

11.7.4 Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.7.5 Ironwood Pharmaceuticals, Inc. Recent Development

11.8 Albireo Pharma, Inc.

11.8.1 Albireo Pharma, Inc. Company Details

11.8.2 Albireo Pharma, Inc. Business Overview

11.8.3 Albireo Pharma, Inc. Chronic Idiopathic Constipation Treatment Introduction

11.8.4 Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.8.5 Albireo Pharma, Inc. Recent Development

11.9 Sucampo Pharmaceuticals, Inc. (Mallinckrodt)

11.9.1 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details

11.9.2 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview

11.9.3 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Introduction

11.9.4 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.9.5 Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development

11.10 Janssen Pharmaceuticals, Inc. (Johnson and Johnson)

11.10.1 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details

11.10.2 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview

11.10.3 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Introduction

11.10.4 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025)

11.10.5 Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer

Allergan plc

Bausch Health

Sanofi

Takeda Pharmaceutical Company

Sebela Pharmaceuticals

Ironwood Pharmaceuticals Inc

Albireo Pharma Inc

Sucampo Pharmaceuticals, Inc. (Mallinckrodt)

Janssen Pharmaceuticals, Inc. (Johnson and Johnson)

List of Tables

Table 1. Global Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Blood Tests

Table 3. Key Players of Sigmoidoscopy

Table 4. Key Players of Colonoscopy

Table 5. Key Players of Balloon Expulsion Test

Table 6. Key Players of Anorectal Manometry

Table 7. Key Players of Colonic Transit Study

Table 8. Key Players of Defecography

Table 9. Global Chronic Idiopathic Constipation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Chronic Idiopathic Constipation Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Chronic Idiopathic Constipation Treatment Market Share by Region (2020-2025)

Table 13. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Chronic Idiopathic Constipation Treatment Market Share by Region (2026-2031)

Table 15. Chronic Idiopathic Constipation Treatment Market Trends

Table 16. Chronic Idiopathic Constipation Treatment Market Drivers

Table 17. Chronic Idiopathic Constipation Treatment Market Challenges

Table 18. Chronic Idiopathic Constipation Treatment Market Restraints

Table 19. Global Chronic Idiopathic Constipation Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Chronic Idiopathic Constipation Treatment Market Share by Players (2020-2025)

Table 21. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2024)

Table 22. Ranking of Global Top Chronic Idiopathic Constipation Treatment Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Chronic Idiopathic Constipation Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Chronic Idiopathic Constipation Treatment, Headquarters and Area Served

Table 25. Global Key Players of Chronic Idiopathic Constipation Treatment, Product and Application

Table 26. Global Key Players of Chronic Idiopathic Constipation Treatment, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Chronic Idiopathic Constipation Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2020-2025)

Table 30. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Type (2026-2031)

Table 32. Global Chronic Idiopathic Constipation Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2020-2025)

Table 34. Global Chronic Idiopathic Constipation Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Chronic Idiopathic Constipation Treatment Revenue Market Share by Application (2026-2031)

Table 36. North America Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 51. Bayer AG Company Details

Table 52. Bayer AG Business Overview

Table 53. Bayer AG Chronic Idiopathic Constipation Treatment Product

Table 54. Bayer AG Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 55. Bayer AG Recent Development

Table 56. Allergan Company Details

Table 57. Allergan Business Overview

Table 58. Allergan Chronic Idiopathic Constipation Treatment Product

Table 59. Allergan Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 60. Allergan Recent Development

Table 61. Bausch Health Company Details

Table 62. Bausch Health Business Overview

Table 63. Bausch Health Chronic Idiopathic Constipation Treatment Product

Table 64. Bausch Health Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 65. Bausch Health Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi Chronic Idiopathic Constipation Treatment Product

Table 69. Sanofi Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. Takeda Pharmaceutical Company Company Details

Table 72. Takeda Pharmaceutical Company Business Overview

Table 73. Takeda Pharmaceutical Company Chronic Idiopathic Constipation Treatment Product

Table 74. Takeda Pharmaceutical Company Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 75. Takeda Pharmaceutical Company Recent Development

Table 76. SEBELA PHARMACEUTICALS Company Details

Table 77. SEBELA PHARMACEUTICALS Business Overview

Table 78. SEBELA PHARMACEUTICALS Chronic Idiopathic Constipation Treatment Product

Table 79. SEBELA PHARMACEUTICALS Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 80. SEBELA PHARMACEUTICALS Recent Development

Table 81. Ironwood Pharmaceuticals, Inc. Company Details

Table 82. Ironwood Pharmaceuticals, Inc. Business Overview

Table 83. Ironwood Pharmaceuticals, Inc. Chronic Idiopathic Constipation Treatment Product

Table 84. Ironwood Pharmaceuticals, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 85. Ironwood Pharmaceuticals, Inc. Recent Development

Table 86. Albireo Pharma, Inc. Company Details

Table 87. Albireo Pharma, Inc. Business Overview

Table 88. Albireo Pharma, Inc. Chronic Idiopathic Constipation Treatment Product

Table 89. Albireo Pharma, Inc. Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 90. Albireo Pharma, Inc. Recent Development

Table 91. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Company Details

Table 92. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Business Overview

Table 93. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Chronic Idiopathic Constipation Treatment Product

Table 94. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 95. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Recent Development

Table 96. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Company Details

Table 97. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Business Overview

Table 98. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Chronic Idiopathic Constipation Treatment Product

Table 99. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue in Chronic Idiopathic Constipation Treatment Business (2020-2025) & (US$ Million)

Table 100. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Chronic Idiopathic Constipation Treatment Picture

Figure 2. Global Chronic Idiopathic Constipation Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Idiopathic Constipation Treatment Market Share by Type: 2024 VS 2031

Figure 4. Blood Tests Features

Figure 5. Sigmoidoscopy Features

Figure 6. Colonoscopy Features

Figure 7. Balloon Expulsion Test Features

Figure 8. Anorectal Manometry Features

Figure 9. Colonic Transit Study Features

Figure 10. Defecography Features

Figure 11. Others Features

Figure 12. Global Chronic Idiopathic Constipation Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Chronic Idiopathic Constipation Treatment Market Share by Application: 2024 VS 2031

Figure 14. Hospitals Case Studies

Figure 15. Gastroenterology clinics Case Studies

Figure 16. Diagnostic Centers Case Studies

Figure 17. Others Case Studies

Figure 18. Chronic Idiopathic Constipation Treatment Report Years Considered

Figure 19. Global Chronic Idiopathic Constipation Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 20. Global Chronic Idiopathic Constipation Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 21. Global Chronic Idiopathic Constipation Treatment Market Share by Region: 2024 VS 2031

Figure 22. Global Chronic Idiopathic Constipation Treatment Market Share by Players in 2024

Figure 23. Global Top Chronic Idiopathic Constipation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Idiopathic Constipation Treatment as of 2024)

Figure 24. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation Treatment Revenue in 2024

Figure 25. North America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. North America Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)

Figure 27. United States Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Canada Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)

Figure 31. Germany Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. France Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. U.K. Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Italy Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Russia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Nordic Countries Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Chronic Idiopathic Constipation Treatment Market Share by Region (2020-2031)

Figure 39. China Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Japan Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. South Korea Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. India Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Australia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)

Figure 47. Mexico Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Brazil Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Chronic Idiopathic Constipation Treatment Market Share by Country (2020-2031)

Figure 51. Turkey Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. UAE Chronic Idiopathic Constipation Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Bayer AG Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 55. Allergan Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 56. Bausch Health Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 57. Sanofi Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 58. Takeda Pharmaceutical Company Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 59. SEBELA PHARMACEUTICALS Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 60. Ironwood Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 61. Albireo Pharma, Inc. Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 62. Sucampo Pharmaceuticals, Inc. (Mallinckrodt) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 63. Janssen Pharmaceuticals, Inc. (Johnson and Johnson) Revenue Growth Rate in Chronic Idiopathic Constipation Treatment Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Chronic Constipation Treatment Drugs Market Research Report 2024

Global Constipation Treatment Drug Market Research Report 2025

Constipation Laxative Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Constipation Nutraceuticals Market Research Report 2024

Global Chronic Disease Treatment Market Research Report 2024

Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Diverticular Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Idiopathic Urticaria Treatment Market Research Report 2024

Chronic Lung Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digestive Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medications for Chronic Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IBS C Drugs Market Research Report 2024

Incontinence Treatment System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Idiopathic Pulmonary Fibrosis Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Intestinal Inflammation Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digestive Distress Treatment Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V18395

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32G20014

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions